Glycosaminoglucans alter the conformation of interferon-gamma

Cytokine

Volumn 12, Issue 5, 2000, Pages 466-471

  Balasubramanian, Vandana ^a   Ramanathan, Murali ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Chondroitin sulfate; Circular dichroism; Extracellular matrix; Fluorescence spectroscopy; Heparin; IFN gamma

Indexed keywords

CHONDROITIN SULFATE; CYTOKINE; DIMER; GAMMA INTERFERON; GLYCOSAMINOGLYCAN; LOW MOLECULAR WEIGHT HEPARIN;

ARTICLE; CIRCULAR DICHROISM; EXTRACELLULAR MATRIX; FLUORESCENCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; ANIMAL; CATTLE; CHEMISTRY; METHODOLOGY; PROTEIN CONFORMATION; PROTEIN QUATERNARY STRUCTURE; SPECTROFLUOROMETRY;

ANIMALS; CATTLE; CHONDROITIN SULFATES; CIRCULAR DICHROISM; GLYCOSAMINOGLYCANS; HEPARIN, LOW-MOLECULAR-WEIGHT; INTERFERON TYPE II; PROTEIN CONFORMATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SPECTROMETRY, FLUORESCENCE;

EID: 0033625769     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1999.0592     Document Type: Article

References (21)

1. Daubener W, Nockemann S, Gutsche M, Hadding U. Heparin inhibits the antiparasitic and immune modulatory effects of human recombinant interferon-gamma. Eur J Immunol. 25:1995;688-692.
2. Korlipara LV, Pleass HC, Taylor RM, Proud G, Forsythe JL, Kirby JA. Cultured endothelium. Heparin antagonizes the induction of class II MHC molecules by interferon-gamma. Transplantation. 58:1994;1426-1429.
3. Rix DA, Douglas MS, Talbot D, Dark JH, Kirby JA. Role of glycosaminoglycans (GAGs) in regulation of the immunogenicity of human vascular endothelial cells. Clin Exp Immunol. 104:1996;60-65.
4. Lortat-Jacob H, Kleinman HK, Grimaud JA. High-affinity binding of interferon-gamma to a basement membrane complex (matrigel). J Clin Invest. 87:1991;878-883.
5. Sadir R, Forest E, Lortat-Jacob H. The heparan sulfate binding sequence of interferon-gamma increased the on rate of the interferon-gamma-interferon-gamma receptor complex formation. J Biol Chem. 273:1998;10919-10925.
6. Lortat-Jacob H, Baltzer F, Grimaud JA. Heparin decreases the blood clearance of interferon-gamma and increases its activity by limiting the processing of its carboxyl-terminal sequence. J Biol Chem. 271:1996;16139-16143.
7. Camejo EH, Rosengren B, Camejo G, Sartipy P, Fager G, Bondjers G. Interferon gamma binds to extracellular matrix chondroitin-sulfate proteoglycans, thus enhancing its cellular response. Arteriosclerosis, Thrombosis Vascular Biol. 15:1995;1456-1465.
8. Lortat-Jacob H, Grimaud JA. Interferon-gamma binds to heparan sulfate by a cluster of amino acids located in the C-terminal part of the molecule. FEBS Letters. 280:1991;152-154.
9. Lortat-Jacob H, Grimaud JA. Binding of interferon-gamma to heparan sulfate is restricted to the heparin-like domains and involves carboxylic - but not N-sulfated - groups. Biochim Biophys Acta. 1117:1992;126-130.
10. Lortat-Jacob H, Turnbull JE, Grimaud JA. Molecular organization of the interferon gamma-binding domain in heparan sulphate. Biochem J. 310:1995;497-505.
11. Lortat-Jacob H, Grimaud JA. Interferon-gamma C-terminal function: new working hypothesis. Heparan sulfate and heparin, new targets for IFN-gamma, protect, relax the cytokine and regulate its activity. Cell Mol Biol. 37:1991;253-260.
12. Epps DE, Raub TJ, Kezdy FJ. A general, wide-rage spectrofluorometric method for measuring the site-specific affinities of drugs toward human serum albumin. Analyt Biochem. 227:1995;342-350.
13. Fasman GD. Distinguishing transmembrane helices from peripheral helices by circular dichrosim. Biotech Appl Biochem. 18:1993;111-138.
14. Hogrefe HH, McPhie P, Bekisz JB, Enterline JC, Dyer D, Webb DS, Gerrard TL, Zoon KC. Amino terminus is essential to the structural integrity of recombinant human interferon-gamma. J Biol Chem. 264:1989;12179-12186.
15. Ealick SE, Cook WJ, Vijay-Kumar S, Carson M, Nagabhushan TL, Trotta PP, Bugg CE. Three-dimensional structure of recombinant human interferon-gamma. Science. 252:1991;698-702.
16. Merz WE. Evidence for impaired subunit interaction in chemically deglycosylated human choriogonadotropin. Biochem Biophys Res Commun. 156:1988;1271-1278.
17. Aloj SM, Edelhoch H, Ingham KC, Morgan FJ, Canfield RE, Ross GT. The rates of dissociation and reassociation of the subunits of human chorionic gonadotropin. Arch Biochem Biophys. 159:1973;497-504.
18. Grimaud JA, Lortat-Jacob H. Matrix receptors to cytokines: from concept to control of tissue fibrosis dynamics. Pathol Res Pract. 190:1994;883-890.
19. Ihrcke NS, Wrenshall LE, Lindman BJ, Platt JL. Role of heparan sulfate in immune system-blood vessel interactions. Immunol Today. 14:1993;500-505.
20. Geller RL, Ihrcke NS, Platt JL. Release of endothelial cell-associated heparan sulfate proteoglycan by activated T cells. Transplantation. 57:1994;770-774.
21. Ihrcke NS, Platt JL. Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: evidence for proteolysis of cell-surface molecules. J Cell Physiol. 168:1996;625-637.